BIOMAT Database Logo BIOMAT Database Logo

[Imidazo(4,5-g)quinolines (author's transl)]. 1975

E Lebenstedt, and W Schunack

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D011804 Quinolines
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

E Lebenstedt, and W Schunack
Imidazo[4,5-f]quinolines III: Antibacterial 7-methyl-9-(substituted arylamino)imidazo[4,5-f]quinolines.
August 1977, Journal of pharmaceutical sciences,
E Lebenstedt, and W Schunack
Imidazo[4,5-f]quinolines. 2. A series of 9-(substituted amino)imidazo[4,5-f]quinolines as antitapeworm agents.
June 1977, Journal of medicinal chemistry,
E Lebenstedt, and W Schunack
Imidazo[4,5-f]quinolines. 4. Synthesis and anthelmintic activity of a series of imidazo[4,5-f]quinolin-9-ols.
March 1978, Journal of medicinal chemistry,
E Lebenstedt, and W Schunack
Imidazo[4,5-c]quinolines as inhibitors of the PI3K/PKB-pathway.
February 2008, Bioorganic & medicinal chemistry letters,
E Lebenstedt, and W Schunack
One-pot Sequential Reactions Featuring a Copper-catalyzed Amination Leading to Pyrido[2',1':2,3]imidazo[4,5-c]quinolines and Dihydropyrido[2',1':2,3]imidazo[4,5-c]quinolines.
June 2015, Chemistry, an Asian journal,
E Lebenstedt, and W Schunack
Synthesis and anti-cancer activity of 1,4-disubstituted imidazo[4,5-c]quinolines.
January 2016, Organic & biomolecular chemistry,
E Lebenstedt, and W Schunack
[Reaction patterns of 2,7-diamino-4,5-dimethyl-imidazo(5,1-f)-as-triazine (author's transl)].
October 1973, Archiv der Pharmazie,
E Lebenstedt, and W Schunack
Efficient metal-free synthesis of various pyrido[2',1':2,3]imidazo- [4,5-b]quinolines.
September 2013, Chemistry (Weinheim an der Bergstrasse, Germany),
E Lebenstedt, and W Schunack
1H-Imidazo[4,5-c]quinoline derivatives as novel potent TNF-alpha suppressors: synthesis and structure-activity relationship of 1-, 2-and 4-substituted 1H-imidazo[4,5-c]quinolines or 1H-imidazo[4,5-c]pyridines.
June 2003, Bioorganic & medicinal chemistry,
E Lebenstedt, and W Schunack
A novel multi-component reaction to imidazo[4,5-g]-quinazolines.
May 2013, Molecules (Basel, Switzerland),
Copied contents to your clipboard!